Drugs that contain Salmeterol Xinafoate
1. Serevent patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXOSMITHKLINE | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXOSMITHKLINE | Inhalation device |
Aug, 2016
(7 years ago) | |
Market Authorisation Date: 19 September, 1997
Treatment: NA
Dosage: POWDER;INHALATION
More Information on Dosage
SEREVENT family patents
